RedHill Biopharma Ltd.

US$0.43As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RDHLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (63.99%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 4.87
PE TTM —
TSR TTM (67.08%)
Mkt cap US$2.602M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.45
5.11%
(30.22%)
Buy 1|1|4|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
7.63%
19.06%
16.61%
32.02%
Revenue$M
0.201
0.196
0.194
0.198
5.51%
(2.76%)
(1.31%)
(2.87%)
Peers (US$2.602M)
Cap (US$)
PE
2.550M
—
Capital
TTM
5Y
10Y
Leveragex
1.852
0.136
0.119
EBIT/Intx
0.862
0.239
0.212
Own earn%
67.76
21.15
21.81
Sh yield%
33.13
38.27
36.95
Owners
Insiders/Inst%
6.83
77.00
Short interest%
4.18
SBC / revenue%
1.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–24
$1 testx
0.0
Incr. ROIC%
11